Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-041408

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James F Tessmer
Officer — VP, Finance & Accounting
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———11,744D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$8.20Feb 11, 2016A19,360A—Feb 11, 2026Common Stock19,36019,360D
Restricted Stock Units (Phantom Stock)F2,F3—Feb 11, 2016A8,300A——Common Stock8,3008,300D
Stock Option (Right to Buy)F4$12.67holding————Feb 23, 2021Common Stock10,00010,000D
Stock Option (Right to Buy)F5$12.60holding————Feb 15, 2022Common Stock8,7148,714D
Restricted Stock Units (Phantom Stock)F2,F6—holding—————Common Stock964964D
Stock Option (Right to Buy)F7$14.63holding————Feb 8, 2023Common Stock7,9997,999D
Restricted Stock Units (Phantom Stock)F2,F8—holding—————Common Stock1,7141,714D
Stock Option (Right to Buy)F9$12.04holding————Feb 6, 2024Common Stock12,49912,499D
Restricted Stock Units (Phantom Stock)F2,F10—holding—————Common Stock4,0174,017D
Stock Option (Right to Buy)F11$6.23holding————Feb 5, 2025Common Stock24,89924,899D
Restricted Stock Units (Phantom Stock)F2,F12—holding—————Common Stock10,67110,671D
Stock Option (Right to Buy)F13$27.58holding————Feb 13, 2017Common Stock1,4281,428D
Stock Option (Right to Buy)F14$24.92holding————Oct 23, 2017Common Stock3,5713,571D
Stock Option (Right to Buy)F15$14.49holding————Feb 7, 2018Common Stock5,7145,714D
Stock Option (Right to Buy)F16$10.15holding————Feb 12, 2019Common Stock21,42821,428D
Stock Option (Right to Buy)F17$13.30holding————Feb 15, 2020Common Stock14,28414,284D

Explanation of responses